𝛼SK or Search

ENTITY

Shilpa Medicare (SLPA IN)

13

Analysis

Health Care • India

Shilpa Medicare Limited is an Indian pharmaceutical company specializing in the development, manufacture, and marketing of high-quality active pharmaceutical ingredients (APIs), formulations, biologics, and specialty chemicals. The company offers a broad range of generic pharmaceutical products, including oncology and non-oncology APIs, oral solids, liquid injections, and lyophilized injectables, operating on a primarily Business-to-Business (B2B) model. It was established in 1987 and is headquartered in Raichur, Karnataka, India.

more

Refresh

Exchange Announcement • 12 Jul 2024 14:53

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Exchange Announcement • 11 Jul 2024 17:48

SHILPA MEDICARE LTD. - 530549 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Exchange Announcement • 09 Jul 2024 18:16

SHILPA MEDICARE LTD. - 530549 - Shilpa Pharma Lifesciences Limited, Unit 2, Raichur, Karnataka Has Cleared The ANVISA-Brazil GMP Inspection

Exchange Announcement • 08 Jul 2024 21:05

SHILPA MEDICARE LTD. - 530549 - Announcement Under ''Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015,Allotment Of Equity Shares By Shilpa Biologicals Pvt. Ltd. (SBPL), A Wholly Owned Subsidiary Of Shilpa Medicare Ltd.

Exchange Announcement • 08 Jul 2024 16:21

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x